glp-1 drugs trump announces deal to sell some weight loss for as low as $150 on TrumpRX Trump unveils deal to expand
Description
Traditionally, Glucagon-like peptide-1 (GLP-1) receptor agonists (GLP-1RAs), a pivotal class of drug, mimics the actions of endogenous Glucagon-like peptide-...
Explore GLP-1 medications like Ozempic and Wegovy
Obesity and type 2 diabetes remain critical global health challenges, with rising prevalence demanding innovative treatment approaches
It can lead to weight loss, better glycemic control, and reduced cardiometabolic risk factors
The recently initiated large-sized FLOW trial investigating the effects of semaglutide on hard renal outcomes in patients with DKD will provide clarity whether GLP-1 receptor agonists may reduce the burden of DKD in addition to their other beneficial metabolic and cardiovascular effects.
